CIK 0001175680 · Non-accelerated filer<br>Smaller reporting company
CytoDyn Inc.
Sign in to watch- Ticker
- CYDY
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753056237
- Phone
- 360-980-8524
- Business address
- 1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
- Former names
- CYTODYN INC, REXRAY CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-08 | Welch David F Director | Grant or award · Warrant (Right to Buy) | +500,000 | 500,000 | ||
| 2019-05-08 | Welch David F Director | Option exercise · Warrant (Right to Buy) | −500,000 | 0 | ||
| 2019-05-08 | Welch David F Director | Returned to the company · Warrants (Right to Buy) | −384,615 | 0 | ||
| 2019-05-08 | Welch David F Director | Grant or award · Warrants (Right to Buy) | +384,615 | 384,615 | ||
| 2019-05-08 | Welch David F Director | Option exercise · Warrants (Right to Buy) | −384,615 | 0 | ||
| 2019-02-16 | Kelly Scott A. Director | Grant or award · Warrants (right to buy) | +500,000 | 500,000 | ||
| 2019-01-10 | Welch David F Director | Grant or award · Stock Option (right to buy) | +38,904 | 38,904 | ||
| 2019-01-10 | Caracciolo Anthony Director | Returned to the company · Stock Options (right to buy) | −100,000 | 0 | ||
| 2019-01-10 | Caracciolo Anthony Director | Grant or award · Stock Options (right to buy) | +100,000 | 100,000 | ||
| 2019-01-10 | Caracciolo Anthony Director | Returned to the company · Stock Options (right to buy) | −50,000 | 0 | ||
| 2019-01-10 | Caracciolo Anthony Director | Grant or award · Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2019-01-08 | Klump Michael A Director | Purchase · Convertible Promissory Note | +500,000 | 500,000 | ||
| 2019-01-08 | Klump Michael A Director | Purchase · Warrants | +500,000 | 500,000 | ||
| 2018-12-22 | Ray Nitya G. See Remarks | Grant or award · Stock Options (right to buy) | +400,000 | 400,000 | ||
| 2018-11-16 | Pestell Richard MD Chief Medical Officer | Grant or award | +8,342,000 | $0.57 | $4.8M | 8,342,000 |
| 2018-11-16 | Pestell Richard MD Chief Medical Officer | Grant or award | +12,782,440 | $0.57 | $7.3M | 21,124,440 |
| 2018-11-16 | Pestell Richard MD Chief Medical Officer | Grant or award · Stock Options (right to buy) | +350,000 | 350,000 | ||
| 2018-11-16 | Pourhassan Nader President and CEO | Grant or award | +161,489 | 161,489 | ||
| 2018-11-16 | Pourhassan Nader President and CEO | Grant or award | +15,750 | 15,750 | ||
| 2018-11-16 | Pourhassan Nader President and CEO | Grant or award · Stock Options (right to buy) | +200,000 | 200,000 |
Page 22 of 33 · 652 trades